Christian Weyer Insider Trading $AMLN AMYLIN PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Christian Weyer.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Christian Weyer. Christian Weyer is SVP, Research & Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and EVP Research and Development in INTERCEPT PHARMACEUTICALS INC ($ICPT) and EVP, Research & Development in INTERCEPT PHARMACEUTICALS, INC. ($ICPT) and See Remarks in FATE THERAPEUTICS INC ($FATE).

Christian Weyer in AMYLIN PHARMACEUTICALS INC

Trading Symbol: AMLN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Christian Weyer: SVP, Research & Development
Holdings: 0 shares
Latest Transaction: Aug 10 2012

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Christian Weyer in AMYLIN PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AMLN, FATE, ICPT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ0.0035,00000
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseH41.3414,320591,9890
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseH36.9012,516461,8400
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ24.8716,027398,5910
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ22.601443,2540
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ18.8583315,7020
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ18.0119,340348,3130
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ16.542,93048,4620
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ16.02123,7581,982,6030
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ15.03113,0271,698,7960
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ9.0213,748124,0070
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseH41.343,680152,1310
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseH36.901,48454,7600
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ24.873,97398,8090
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ22.6093721,1760
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ19.791,20823,9060
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ18.017,360132,5540
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ16.542,63343,5500
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ16.026,24299,9970
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ15.0311,973179,9540
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseJ9.026,25256,3930
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...SellJ31.003,15997,92903.2 K to 0 (-100.00 %)
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...SellJ31.004,815149,2653,1598 K to 3.2 K (-60.38 %)
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...SellJ31.0035911,1290359 to 0 (-100.00 %)
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...SellJ31.0088627,4660886 to 0 (-100.00 %)
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...SellJ31.0045314,0438861.3 K to 886 (-33.83 %)
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...SellJ31.001,01231,37201 K to 0 (-100.00 %)
Aug 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...SellJ31.0033,1951,029,0451,01234.2 K to 1 K (-97.04 %)
Jul 26 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...GrantA14.623957034,20734.2 K to 34.2 K (+0.11 %)
Mar 07 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseA16.02123,7581,982,603123,758
Mar 07 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseA16.026,24299,9976,242
Mar 07 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...GrantA0.001,52907,9746.4 K to 8 K (+23.72 %)
Mar 07 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...GrantA0.0010,000034,16824.2 K to 34.2 K (+41.38 %)
Mar 02 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...SellS17.111,23121,06224,16825.4 K to 24.2 K (-4.85 %)
Feb 24 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...SellS17.032,51942,89924,59727.1 K to 24.6 K (-9.29 %)
Feb 24 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...GrantA0.006,700027,11620.4 K to 27.1 K (+32.82 %)
Feb 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...SellS16.623,84363,85320,41624.3 K to 20.4 K (-15.84 %)
Feb 10 2012AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...GrantA0.0010,000024,25914.3 K to 24.3 K (+70.13 %)
Mar 03 2011AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseA15.03113,0271,698,796113,027
Mar 03 2011AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...Option ExerciseA15.0311,973179,95411,973
Mar 03 2011AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...GrantA0.001,63006,4454.8 K to 6.4 K (+33.85 %)
Mar 03 2011AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...GrantA0.0010,000013,4833.5 K to 13.5 K (+287.11 %)
Nov 19 2010AMLNAMYLIN PHARMACEUTI ...Weyer ChristianSVP, Research & Dev ...SellS13.421,31417,6343,3574.7 K to 3.4 K (-28.13 %)

Page:   1

Contact us | Follow us on Twitter